Salzman NH, Polin RA, Harris MC, Ruchelli E, Hebra A, Zirin-Butler S, et al. Enteric defensin expression in necrotizing enterocolitis. Pediatr Res 1998;44:20-6. Darmoul D, Brown D, Selsted ME, Ouellette AJ. Cryptdin gene expression in developing mouse small intestine. Am J Physiol 1997;272:G197-206.

Condon MR, Viera A, D'Alessio M, Diamond G. Induction of a rat enteric defensin gene by hemorrhagic shock. Infect Immun 1999;67:4787-93.

Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002;70:953-63.

Nitschke M, Wiehl S, Baer PC, Kreft B. Bactericidal activity of renal tubular cells: the putative role of human beta defensins. Exp Nephrol 2002;10:332-7.

Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T. Human beta-Defensin-

1: an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101:1633^-2.

Frye M, Bargon J, Gropp R. Expression of human ß-defensin-1 promotes differentiation of keratinocytes. J Mol Med 2001 ;79:275-82.

Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as potential regulator. Nat Med 2001 ;7:180-5. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, et al. Discovery of five conserved ß-defensin gene clusters using a computational search strategy. PNAS 2002;99: 2129-33.

Moser C, Weiner DJ, Lysenko E, Bals R, Weiser JN, Wilson JM. ß-defensin 1 contributes to pulmonary innate immunity in mice. Infection Immun 2002;70:3068-72.

42. Morrison GM, Kilanowski F, Davidson D, Dorin J. Characterization of the mouse beta defensin \ ,Dfb\, mutant mouse model. Infection Immun 2002;70:3053-60.

43. Bajaj-Elliott M, Fedeli P, Smith GV, Domizio P, Maher L, Ali RS, et al. Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis. Gut 2002;51: 356-61.

44. O'Neil DA, Cole SP, Martin-Porter E, Housley MP, Liu L, Ganz T, et al. Regulation of human (i-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infection Immun 2002;68:5412-15.

45. Diamond G, Russell JP, Bevins CL. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. PNAS 1996;93:5156-60.

46. Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev 2000;173:27-38.

47. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L, et al. Human (i-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and state of differentiation. J Invest Dermatol 2002; 118:275-81.

48. Fehlbaum P, Rao M, Zasloff M, Anderson GM. An essential amino acid induces epithelial (3-defensin expression. PNAS 2000;97:12723-8.

49. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002;14:129-35.

50. Cole AM, Shi J, Ceccarelli A, Kim Y, Park A, Ganz T. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 2001;97:297-304.

51. S0rensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001 ;97:3951-9.

52. Ying QL, Simon SR. Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin. Biochemistry 1993;32:1866-74.

53. DuBois RM, Bernaudin JF, Paakko P, Hubbard R, Takahashi H, Ferrans V, et al. Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-antitrypsin. Blood 1991;77:2724-30.

54. Bless NM, Smith D, Charlton J, Czermak BJ, Schmal H, Friedl HP, et al. Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury. Curr Biol 1997;7:877-80.

55. Aarbiou J, Rabe KF, Hiemstra PS. Role of defensins in inflammatory lung disease. Ann Med 2002;34:96-101.

56. Schmidtchen A, Frick IM, Andersson E, Tapper H, Bjorck L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 2002;46:157-68.

57. Paone G, Wada A, Stevens LA, Matin A, Hirayama T, Levine RL, et al. ADP ribosylation of human neutrophil peptide-1 regulates its biological properties. PNAS 2002;99:8231-5.

58. Gorter AD, Hiemstra PS, de Bentzmann S, van Wetering S, Dankert J, van Alphen L. Stimulation of bacterial adherence by neutrophil defensins varies among bacterial species but not among host cell types. FEMS Immun Med Microbiol 2000;28:105-11.

59. Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like l(FPRLl) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000; 192:1069-74.

Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I. Evaluation of the effects of peptide antibiotics human beta defensins-l/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol 2002;31:1066-75. Niyonsaba F, Iwabuchi K, Matsuda H, Ogawa H, Nagaoka I. Epithelial cell derived human b-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Internat Immunol 2002; 14:421-6. Biragyn A, Rufini, PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, et al. Tolllike receptor 4-dependent activation of dendritic cells by ß-defensin 2. Science 2002;298: 1025-30.

Perregaux DG, Bhavsar K, Contillo L, Shi J, Gabel CA. Antimicrobial peptides initiate IL-lß posttranslational processing: a novel role beyond innate immunity. J Immunol 2002;168:3024-32.

van Wetering S, Mannesse-Lazeroms SP, Dijkman JH, Hiemstra PS. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leukoc Biol 1997;62:217-26.

Aarbiou J, Ertmann M, van Wetering S, van Noort P, Rook D, Rabe K, et al. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol 2002;72:167-74.

Li J, Post M, Volk R, Gao Y, Li M, Metais C, et al. PR39, a peptide regulator of angiogenesis. Nat Med 2000;6:49-55.

van Wetering S, van der Linden AC, van Sterkenburg MA, de Boer WI, Kuijpers AL, Schwalkwijk J, et al. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol 2000;278:L51-8. Ichinose M, Asai M, Imai K, Sawada M. Enhancement of phagocytosis by corticostatin I (CSI) in cultured mouse peritoneal macrophages. Immunopharmacology 1996;35:103-9. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-8.

Le Y, Yang Y, Cui Y, Yazawa H, Gong W, Qui C, et al. Receptors for chemotactic formyl peptides as pharmacological targets. Int Immunopharmacol 2002;2:1-13. van Wetering S, Mannesse-Lazeroms SPG, van Strekenburg MA, Hiemstra PS. Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone. Inflamm Res 2002;51:8-15.

Travis SM, Conway BD, Zabner J, Smith JJ, Anderson NN, Singh PK, et al. Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol 1999;20: 872-9.

Singh PK, Tack BF, McCray PB Jr., Welsh MJ. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 2000;279 :L799-805.

Ouellette AJ, Bevins, CL. Paneth cell defensins and innate immunity of the small bowel. Inflamm Bowel Dis 2001 ;7:43-50.

Valore EV, Park CH, Igreti SL, Ganz T. Antimicrobial components of vaginal fluid. Am J Obstet Gynecol 2002;187:561-568.

Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, et al. Lipid mediator induced expression of bactericidal/permeability increasing protein (BPI) in human mucosal epithelia. PNAS 2002;99:3902-7.

Prohaszka Z, Nemet K, Csermely P, Hudecz F, Mezo G, Fust G. Defensins purified from human granulocytes bind Clq and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1. Mol Immunol 1997;34:809-16.

Chertov P, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin 8-stimulated neutrophils. J Bio Chem 1996;271:2935^10.

Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, et al. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol 2000;12:691-700.

Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl Med 2002;347:

Natural Treatments For Psoriasis

Natural Treatments For Psoriasis

Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.

Get My Free Ebook

Post a comment